| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/08/2004 | US20040132737 especially dimethylphenylpiperazinium; treating a variety of pulmonary diseases with fewer side effects than other anti-inflammatory drugs, such as steroids |
| 07/08/2004 | US20040132729 Inhibitors of p38 |
| 07/08/2004 | US20040132724 e.g., cis-1-Acetyl-6-ethyl-N-(4-ethylphenyl)-1,2,3,4-tetrahydro-2-methyl-4-quinolinamine; atopic dermatitis, urticaria, various allergies bullous pemphigoid, industrial sensitization, chronic transplant rejection and COPD |
| 07/08/2004 | US20040132721 Treatment of airway disorders |
| 07/08/2004 | US20040132710 Lactams as tachkinin antagonists |
| 07/08/2004 | US20040132700 Use of fluticasone propionate in the treatment of diseases ameliorated by enhancement of epithelial madrix adhesion such as asthma cystic fibrosis and influenza |
| 07/08/2004 | US20040132694 6-Chloro-3-(3,4-dioxo-2-phenylamino-cyclobut-1-enylamino)-2-hydroxy-benzamide; psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease |
| 07/08/2004 | US20040132685 Immunostimulatory nucleic acid |
| 07/08/2004 | US20040132636 Pharmaceutical uses for alpha2delta ligands |
| 07/08/2004 | US20040132163 Biological materials and uses thereof |
| 07/08/2004 | US20040132139 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/08/2004 | US20040132053 Sphingosine kinase enzyme |
| 07/08/2004 | US20040132038 Membrane protein for use as diagnostic tool in the detection and prevention of cell proliferative, cardiovascular, skin, nervous system, respiratory and metabolic disorders |
| 07/08/2004 | US20040131703 Antiinflammatory agents; respiratory system disorders |
| 07/08/2004 | US20040131609 Ultra high affinity neutralizing antibodies |
| 07/08/2004 | US20040131589 Materials and methods for inhibition of IgE production |
| 07/08/2004 | US20040131555 Mixture of tobramycin in carrier; aerosols; respiratory system disorders |
| 07/08/2004 | CA2511726A1 Xanthine derivatives as muscarinic receptor antagonists |
| 07/08/2004 | CA2508624A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/08/2004 | CA2507613A1 Methods of diagnosis and treatment of interstitial lung disease |
| 07/07/2004 | EP1435353A1 Novel heterocyclic compound and anti-inflammatory agent |
| 07/07/2004 | EP1435238A1 Methods for treating apnea and apnea disorders using optically pure R (+) ondansetron |
| 07/07/2004 | EP1434860A2 Enzymes |
| 07/07/2004 | EP1434796A2 Secreted proteins |
| 07/07/2004 | EP1434788A2 Proteins associated with cell growth, differentiation, and death |
| 07/07/2004 | EP1434785A2 Protein modification and maintenance molecules |
| 07/07/2004 | EP1434775A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 07/07/2004 | EP1434769A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 07/07/2004 | EP1434765A1 Substituted piperidines with selective binding to histamine h3-receptor |
| 07/07/2004 | EP1434763A2 Beta-lactamyl vasopressin v1a antagonists |
| 07/07/2004 | EP1434624A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
| 07/07/2004 | EP1434594A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 07/07/2004 | EP1434587A1 Pharmaceutical combinations comprising salmeterol and fluticasone proprionate for the treatment of asthma |
| 07/07/2004 | EP1434585A1 Alkyne matrix metalloproteinase inhibitors |
| 07/07/2004 | EP1434583A1 N-aroyl piperazine derivatives as orexin receptor antagonists |
| 07/07/2004 | EP1434579A1 Imidazole derivatives as antiinflammatory agents |
| 07/07/2004 | EP1434577A1 Pyrrolidinone derivatives |
| 07/07/2004 | EP1230222B1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 07/07/2004 | EP1218359B1 Piperazine compounds as tachykinins antagonists |
| 07/07/2004 | EP1087971B1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 07/07/2004 | EP0946552B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/07/2004 | CN1511159A Nitrogen-based camptothecin derivatives |
| 07/07/2004 | CN1511155A Amido ether substituted imidazoquinolines |
| 07/07/2004 | CN1511149A 2-thio-substituted imidazole derivatives and use therof in pharmaceutical industry |
| 07/07/2004 | CN1511138A Access parameter adaptation and packet data resource management using detailed mobile status information |
| 07/07/2004 | CN1511137A Hydro phobic polyamine analogs and methods for their use |
| 07/07/2004 | CN1511043A Pregabalin lactose conjugates |
| 07/07/2004 | CN1511042A PD 4 inhibitor and anti-cholinergic agent in combination for treating obstructive airways diseases |
| 07/07/2004 | CN1511035A Gatifloxacin pentahydrate |
| 07/07/2004 | CN1511033A Liquid drug preparations |
| 07/07/2004 | CN1511031A Solid pharmaceutical formulations comprising modafinil |
| 07/07/2004 | CN1509729A Yanning adjuvant |
| 07/07/2004 | CN1509714A Rifaximin spray |
| 07/07/2004 | CN1156480C Water soluble SDZ-RAD esters, its preparation method, use and composition thereof |
| 07/07/2004 | CN1156478C Substituted porphyrins |
| 07/07/2004 | CN1156477C Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase |
| 07/07/2004 | CN1156454C Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 07/07/2004 | CN1156452C Compound as anti-inflammatory agent |
| 07/07/2004 | CN1156451C Betz 2-adrenoceptor agonists |
| 07/07/2004 | CN1156300C Preparing process and prescription of loquat syrup for treating cough |
| 07/07/2004 | CN1156299C Health-care tea as cigarette companion and its preparation method |
| 07/06/2004 | US6759535 A 3-amide-methyl- or 3-urea-isoquinoline derivatives, enzyme inhibitor of protein kinase, for treating cell proliferation, cell death, inflammatory diseases, autoimmune diseases, bone disorders, infectious diseases, viral diseases |
| 07/06/2004 | US6759431 Compositions and methods for treating or preventing diseases of body passageways |
| 07/06/2004 | US6759430 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/06/2004 | US6759424 Imidazolidine derivatives, their preparation, their use, and pharmaceutical preparations comprising them |
| 07/06/2004 | US6759422 Administering benzothiazole compound for therapy, prophylaxis of disease |
| 07/06/2004 | US6759420 Low molecular weight, factor xa specific blood clotting inhibitors without side effects |
| 07/06/2004 | US6759415 Affinity with subtypes of somatostatin receptors |
| 07/06/2004 | US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 07/06/2004 | US6759398 Anti-inflammatory androstane derivative |
| 07/06/2004 | US6759387 Delivery enhancing transporter that has sufficient guanidino or amidino sidechain moieties to enhance delivery of a compound conjugated to the reagent across one or more layers of the tissue |
| 07/06/2004 | US6759208 Prevention, therapy disease; forming tritiated water; calibration |
| 07/06/2004 | US6759194 Nucleotide sequences encoding peroxisome-associated polypeptides, and their uses in the diagnosis and/or treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 07/06/2004 | US6759049 Pharmaceutical or dietetic mushroom-based compositions |
| 07/06/2004 | US6759042 Use of cross-linked, covalently bound urokinase plasminogen activator (scuPA)-urokinase plasminogen activator receptor (suPAR) complex as a fibrinolytic agent |
| 07/06/2004 | US6758840 Drug delivery device |
| 07/06/2004 | CA2085201C New pyridyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/01/2004 | WO2004054977A1 Nicotinamide-based kinase inhibitors |
| 07/01/2004 | WO2004054616A1 Antagonist and agonist binding to strong binding site of chemokine receptor |
| 07/01/2004 | WO2004054577A1 Alpha-2-delta ligands to treat ocd and related diseases |
| 07/01/2004 | WO2004054563A1 Alpha-2-delta ligand for the treatment of sexual dysfunction |
| 07/01/2004 | WO2004054559A1 Alpha2delta ligands for different pharmaceutical uses |
| 07/01/2004 | WO2004043912A3 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 07/01/2004 | WO2004019865A3 Amelioration of effects of cigarette smoke |
| 07/01/2004 | WO2004002420A3 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
| 07/01/2004 | WO2003100435A3 Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2) |
| 07/01/2004 | WO2003093297A3 Protein kinase modulators and methods of use |
| 07/01/2004 | WO2003086325A3 Cyanamides useful as reversible inhibitors of cysteine proteases |
| 07/01/2004 | WO2003057822A9 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 07/01/2004 | WO2003042240A3 Polypeptides of pseudomonas aeruginosa |
| 07/01/2004 | US20040127713 relaxing action of tracheal smooth muscles, inhibition of airway hypersensitivity and inhibition of infiltration of inflammatory cells into the airway; useful as antiasthmatic drugs |
| 07/01/2004 | US20040127707 Novel phthalazinones |
| 07/01/2004 | US20040127567 cystic fibrosis; or a chronic inflammatory disorder, e.g., ulcerative colitis, Crohn's disease, chronic pancreatitis, asthma, rheumatoid arthritis or chronic gastritis; abrogated fetal lung surfactant biosynthesis |
| 07/01/2004 | US20040127565 Quarternary ammonium compounds |
| 07/01/2004 | US20040127544 Mannich base prodrugs of 3-(Pyrrol-2-yl-methylidene)-2-indolinone derivatives |
| 07/01/2004 | US20040127542 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 07/01/2004 | US20040127537 Stable liquid parenteral parecoxib formulation |
| 07/01/2004 | US20040127532 Method for synthesizing leflunomide |
| 07/01/2004 | US20040127528 Metalloproteinase inhibitors |
| 07/01/2004 | US20040127513 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease |